anc

Tour de France teams preparing for August start as coronavirus delays race

Cycling's most famous event may still go ahead this year, despite the French Government banning mass gatherings in the country until at least the middle of July.




anc

Chance for AFLW and other women's leagues to reboot after COVID-19

Women's sport, like most things, will look different post COVID-19 — but that isn't necessarily a negative, writes Kim Encel.




anc

Are car rallies possible in the age of social distancing? Targa Australia thinks so

There might be no crowds at the start and finish lines, and drivers would get Zoom briefings, but Targa Australia says it hopes to still deliver its Far North Queensland tarmac rally in September if some restrictions are lifted.




anc

Players who breached social-distancing rules put NRL restart at risk, Federal Sport Minister says

Federal Minister Richard Colbeck says he hopes sport halted by the coronavirus pandemic can get started again, but warns NRL players' misbehaviour threatens a return of play.




anc

The Last Dance dives into the sketchier side of Michael Jordan's legacy

Michael Jordan is remembered as the greatest basketball player ever, but memories of his time in the sun often don't extend beyond the hardwood and when they do, it's not always pretty.




anc

NRL players who refuse flu shot can still play 'under compelling circumstances'

The NRL announces players who choose not to have the flu vaccination on religious, medical or conscientious grounds will be allowed to train and play, but they must sign a revised waiver.




anc

Questions may linger over Michael Jordan and The Last Dance. But just enjoy the show

Questions have been raised around the making of the new Michael Jordan documentary, or why it even exists. But maybe we should just enjoy the show, writes Paul Kennedy.




anc

Adelaide Crows avoid police sanction over social distancing 'mistake'

The Adelaide Crows will be dealt with in an "educative way rather than a punitive way", police say, after players broke coronavirus quarantine guidelines during a training session.




anc

Review: Indie drama 'Working Man' veers off course despite strong performance by Peter Gerety

Veteran character actor Peter Gerety has a meaty role in Richard Jury's "Working Man" even as the movie shifts from quiet dignity into melodrama.




anc

Could a 'controlled avalanche' stop the coronavirus faster, and with fewer deaths?

Israeli scientists say they can mimic the effects of a vaccination campaign if certain people willingly get infected with the coronavirus and recover.




anc

Governors say they'll ease virus restrictions, with an abundance of caution

The governors of Colorado and New York outlined plans to ease pandemic restrictions but stressed they were moving with caution.




anc

Colorado, Tennessee and other states ease coronavirus restrictions; New York cancels presidential primary

Colorado, Montana and Tennessee are among states to reopen amid coronavirus outbreak.




anc

Syrian President Bashar Assad faces rare dissent from a top financial ally, cousin Rami Makhlouf

Syria's Bashar Assad faces dissent from his rich cousin Rami Makhlouf




anc

Coronavirus: What could a socially-distanced bar look like?

How bars and restaurants could look when coronavirus restrictions are eased.




anc

Stream #WithMe: YouTubers dance, cook and quiz in livestream for NHS

Stars like Saffron Barker, Big Narstie and Yammy take part in a four-hour event to raise money.




anc

The Last Dance: 'I did not anticipate this reaction'

Jason Hehir speaks to the BBC about interviewing Michael Jordan and why the documentary series has had such an impact.




anc

Geneva Healthcare Garners $6,193,845 New Financing Round

Revolutionizing cardiac device data management




anc

Blackline Systems Lands $146,000,000 New Financing Round

BlackLine (NASDAQ: BL) is the worlds most trusted solution for Finance Controls & Automation for delivering powerful real-time automation to accounting & finance teams.




anc

Delta ID Obtains $8,964,002 New Financing Round

Delta ID provides the most convenient authentication solution to secure your digital ID.




anc

Solovis Receives $1,250,000 New Financing

You’re not just getting great software. We’ve sat in your seat and wished there was a better way, so we built it. We provide a multi-asset class portfolio management and reporting system.




anc

Former Love Island contestant says she's 'glad' the show has been cancelled

Mental health advocate Malin Andersson reacted to the news that the ITV2 dating show has been shelved




anc

Molly-Mae and Tommy Fury's anger as dozens ignore lockdown rules in Ancoats

The pair shared video of people gathering in the sunshine




anc

KRPA urges state govt to bring pharmacists under insurance cover on lines of healthcare workers engaged in treating COVID─19 patients




anc

Finance ministry set to extend anti─dumping duty on import of sodium citrate from China




anc

MTaI urges govt to provide relief to medical devices cos to come out of COVID─19─induced financial crisis and logistics bottlenecks




anc

AIOCD urges govt to provide insurance cover to chemists to strengthen fight against COVID─19




anc

Union health minister calls upon all scientific depts to develop enhanced synergy for better results




anc

Manufacturer forms alliance to cope with the demand for PPE

Manufacturer and designer, Placon, has introduced the Face Shield Alliance to provide healthcare workers and first responders with adequate Personal Protective Equipment (PPE) during the Covid-19 pandemic.




anc

Huffington Post: Data Exclusivity: Getting the Balance Right

Huffington Post: Data Exclusivity: Getting the Balance Right      A great article on the downsides of cutting or removing data exclusivity provisions for biologics.  The article points out that data protection is needed to enhance safety and create incentives to research and produce new innovative drugs that cost billions of dollars.  However, the author argues that the period must be […]




anc

Crescendo links with CRUK to progress cancer therapy

The charity's Centre for Drug Development will sponsor and fund a future Phase I clinical trial for CB213




anc

ICR welcomes new advanced prostate cancer treatment guideline

NHS England has expanded access to targeted hormone therapies for advanced prostate cancer




anc

E&C Leaders Announce Committee Teleconference Forum on COVID-19 Testing, Contact Tracing and Surveillance on May 8

Energy and Commerce Chairman Frank Pallone, Jr. (D-NJ) and Ranking Member Greg Walden (R-OR) today announced that the Full Committee will hold a teleconference forum on Friday, May 8, at 12 pm (EDT) on COVID-19 testing, contact tracing and surveillance. “Our nation cannot effectively combat this terrible pandemic in the weeks and months ahead without significant testing, contact tracing and surveillance,” Pallone and Walden said.  “We look forward to hearing from health experts about what actions they believe are necessary to ensure our communities have the resources they need to fight this pandemic and to confidently reopen their local economies.” During the forum, the Committee will hear from three health experts:  Andy Slavitt, former Acting Administrator of the Centers for Medicare & Medicaid Services (CMS) from 2015-2017.  Mark McClellan, M.D., Ph.D., former Administrator of CMS from 2004-2006 and former Commissioner of the Food and Drug Administration (FDA) from 2002-2004.  Avik Roy,Co-founder and President of the Foundation for Research on Equal Opportunity. This forum is open to the press.  Credentialed reporters interested in listening to the forum live should RSVP to cj.young@mail.house.gov by 4 pm today, Thursday, May 7. ###




anc

Encouraging Signals for New Cancer Cell Therapy Strategies

Chimeric antigen receptor T-cell therapies have shown remarkable efficacy in leukemia and lymphoma patients who relapsed or were refractory to several prior treatments, but many challenges remain in the cancer cell therapy field. Strategies that may improve upon first-generation therapies were presented during the American Association for Cancer Research virtual meeting with encouraging early activity, […]




anc

Novartis Drug Wins FDA Approval for Lung Cancers With Specific Mutation

As cancer research reveals the genetic basis of the disease, pharmaceutical companies are pursuing targeted therapies that address certain groups of patients. One such drug from Novartis won FDA approval Wednesday, making it the first therapy cleared by the agency to treat patients whose non-small cell lung cancer (NSCLC) carries a certain genetic mutation. The […]




anc

Ayala’s IPO Raises $55M to Test Two Former Bristol Myers Cancer Drugs

Ayala Pharmaceuticals has two clinical-stage cancer drugs licensed from Bristol Myers Squibb. Now it has $55 million to take those drugs further than the pharmaceutical giant did. On Thursday evening, Ayala priced its IPO, which consisted of 3.7 million shares sold for $15 each. That price was the midpoint of the targeted $14 to $16 […]




anc

Eli Lilly Gets Edge in the “RET” Race With FDA Nod for Cancer Drug

Eil Lilly received accelerated FDA approval Friday for a drug that treats advanced cancers carrying a certain genetic signature. It’s the latest targeted cancer therapy to pass the regulatory bar and the first that addresses tumors characterized by aberrations in one particular gene. The gene in question, RET, produces a protein involved in cell signaling. […]




anc

Former Ergomed CEO appointed as Midatech’s Chief Financial Officer

Immunotherapy-focused pharmaceutical company Midatech Pharma has appointed Stephen Stamp as Chief Financial Officer (CFO) with immediate effect.

He will be replacing Nick Robbins-Cherry, who has stepped down after five years since joining in 2014. Robbins will nevertheless remain at Midatech until October to facilitate Stamp’s handover in an orderly fashion.

Stamp has most recently served as CEO of pharmaceutical firm Ergomed for two years, stepping down in January citing health reasons. Prior to this he was CFO at Ergomed for a year beginning in 2016.

read more




anc

Alligator Bioscience hires Chief Financial Officer in interim capacity

Andreas Johannesson has been announced as Alligator Bioscience’s new interim Chief Financial Officer (CFO), replacing ex-CFO Per-Olof Schrewelius who it was previously confirmed will no longer serve the company.

Johannesson’s career has spanned 15 years in the consumer goods sector, with him managing the finances of firms including TeamOlmed, Stenqvist, Fitness23Seven and Haldex.

He spent a further nine years of his career as a strategic consultant with a focus on consumer goods, five of which were spent at global consulting firm McKinsey & Company.

read more




anc

Genmab announces newly-created Chief Financial Officer appointment

Genmab has announced the establishment of the new position of Chief Operating Officer at the company, and has furthermore named Anthony Mancini to the post. In this new role, he will oversee the company’s commercial strategies, including corporate development, business development and information technology functions

read more




anc

At Joe Biden’s Urging, Airbnb, WeWork, And Others Commit To Help Cancer Patients

The companies are committing to find ways to use their businesses to help patients with cancer.




anc

Three Things to Look for in a Patient Assistance Program

Today’s guest post comes from Rob Brown, Vice President and General Manager of RxCrossroads by McKesson and Biologics by McKesson.

Rob discusses the importance of access, adherence, and affordability for specialty therapy patients who are uninsured, underinsured, or low-income. He describes three criteria companies should use to evaluate patient assistance program solutions.

Click here to learn more about program pharmacy solutions for biopharma from RxCrossroads by McKesson.

Read on for Rob’s insights.
Read more »
        




anc

What Is Payer Intelligence—And How Can It Be Combined With Technology to Enhance Patient Access?

Today’s guest post comes from Scott Dulitz, Chief Strategy Officer at TrialCard. Scott discusses how combining payer intelligence with market-leading technology can enhance patient access.

TrialCard recently acquired Policy Reporter, a healthcare software solutions company that provides payer intelligence to the biopharmaceutical, medical device, and diagnostics industries. To learn more, schedule a demo of Policy Reporter or contact Scott (scott.dulitz@trialcard.com).

You can also register for Trialcard’s upcoming webinar: Leveraging Payer Intelligence in Patient Service Programs.

Read on for Scott’s insights.
Read more »
        




anc

Early Detection: A New Front in the War on Cancer

Blood tests that find malignancies before they spread could transform our approach to treatment

-- Read more on ScientificAmerican.com




anc

Heat and Humidity Are Already Reaching the Limits of Human Tolerance

Events with extreme temperatures and humidity are occurring twice as often now as they were 40 years ago

-- Read more on ScientificAmerican.com




anc

John Ratliff of Covance Elected 2018 ACRO Chairman

WASHINGTON–(BUSINESS WIRE)–The Association of Clinical Research Organizations (ACRO) is pleased to announce that its Board of Directors has elected John Ratliff, CEO of Covance Drug...




anc

Advancing the Adoption of Risk-Based Monitoring Strategies in Clinical Trials

On July 17, 2019, under cooperative agreement with the FDA, the Duke-Margolis Center for Health Policy (Duke Margolis) held a public workshop. The event, titled Improving the Implementation of Risk-Based Monitoring Approaches of Clinical Investigations, aimed to identify opportunities to improve Risk Based Monitoring (RBM) implementation and solicit stakeholder input on the challenges, barriers, and enablers that impact the successful adoption of RBM.




anc

ACRO hosts Congressional Briefing on clinical research advancements

On Wednesday, October 23, 2019, ACRO hosted a Congressional Briefing on Capitol Hill. With the help of the Congressional Research & Development...




anc

The world needs a coronavirus vaccine. But it will take time | Patrick Vallance

Any vaccine has to work, but it also has to be safe. Making it happen is one of the government’s biggest priorities

• Patrick Vallance is the UK government chief scientific adviser

Covid-19 has made fundamental and long-lasting changes to the way we live our lives, not just in the UK, but across the world.

As we continue with social-distancing measures and deal with the most immediate issue of reducing the number of cases to protect the NHS and save lives, and keeping R, which is the average infection rate per person, below one, we also need to progress ways to tackle the disease in the longer term.

The vaccines taskforce will be working in lockstep with the public and private sector

Related: New UK taskforce to help develop and roll out coronavirus vaccine

Continue reading...




anc

South Korean researchers start testing pancreatitis drug in COVID-19 patients

The South Korean Ministry of Food and Drug Safety have approved a local trial to evaluate nafamostat’s effectiveness in COVID-19 patients.




anc

Phase 3 Libtayo monotherapy trial halted early due to strong benefit in advanced non-small cell lung cancer

A Phase 3 study of Sanofi and Regeneron’s Libtayo (cemiplimab) as a monotherapy for advanced or metastatic non-small cell lung cancer (NSCLC) has been stopped early after showing strong overall survival benefit, it has emerged.